Leonteq Securities AG’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Hold
50,000
0.01% 545
2026
Q1
$145K Sell
50,000
-50,000
-50% -$107K 0.01% 661
2025
Q4
$161K Hold
100,000
﹤0.01% 708
2025
Q3
$168K Hold
100,000
0.01% 631
2025
Q2
$121K Buy
100,000
+60,000
+150% +$87K ﹤0.01% 682
2025
Q1
$50.8K Sell
40,000
-14,220
-26% -$37.1K ﹤0.01% 827
2024
Q4
$176K Hold
54,220
0.01% 571
2024
Q3
$178K Hold
54,220
0.01% 512
2024
Q2
$230K Buy
+54,220
New +$528K 0.02% 452
2021
Q1
Sell
-500
Closed -$11.4K 1057
2020
Q4
$11.4K Buy
+500
New +$11.5K ﹤0.01% 907

Other funds holding MGNX

Leonteq Securities AG's MGNX Position: Q2 2026 in Review

Leonteq Securities AG held its MacroGenics (MGNX) position steady in Q2 2026 at 50,000 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #545.

Leonteq Securities AG first reported a position in MGNX in Q4 2020 and has held it in 10 quarters since. 121 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Leonteq Securities AG held 50,000 shares of MacroGenics worth $231K as of Q2 2026.
  • Leonteq Securities AG left its MacroGenics share count unchanged in Q2 2026.
  • MacroGenics made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #545 holding.
  • Leonteq Securities AG first reported a position in MacroGenics in Q4 2020 and has held it in 10 quarters since.
  • 121 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.